Home/Filings/4/0000105770-26-000002
4//SEC Filing

HAUGEN JANET BRUTSCHEA 4

Accession 0000105770-26-000002

CIK 0000105770other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 12:37 PM ET

Size

6.1 KB

Accession

0000105770-26-000002

Insider Transaction Report

Form 4
Period: 2025-12-31
Transactions
  • Award

    Phantom Stock Unit

    2025-12-31$275.14/sh+46$12,656208.3 total
    Common Stock (46 underlying)
Holdings
  • Common Stock

    1,320.262
Footnotes (2)
  • [F1]Reflects 1,071 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
  • [F2]Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001185136

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 12:37 PM ET
Size
6.1 KB